União Europeia - francês - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals pour felidae, - chats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. des immunités ont été démontrées une semaine après la primovaccination pour les composants rhinotrachéite, calicivirus, chlamydophila felis et panleucopénie. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

União Europeia - francês - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals pour felidae, - chats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

União Europeia - francês - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - vaccins - tritanrix hepb est indiqué pour l'immunisation active contre la diphtérie, le tétanos, la coqueluche et l'hépatite b (vhb) chez les nourrissons à partir de six semaines (voir la section 4)..

Canadá - francês - Health Canada

sanofi pasteur limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémaglutinine-souche b - suspension - 15mcg; 15mcg; 15mcg - hémagglutinine-souche a (h1n1) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémaglutinine-souche b 15mcg - vaccines

Canadá - francês - Health Canada

sanofi pasteur limited - vaccin contre l'hépatite a, inactivé - suspension - 800unité - vaccin contre l'hépatite a, inactivé 800unité - vaccines

Canadá - francês - Health Canada

sanofi pasteur limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémagglutinine-souche b (victoria); hémagglutinine-souche b (yamagata) - suspension - 7.5mcg; 7.5mcg; 7.5mcg; 7.5mcg - hémagglutinine-souche a (h1n1) 7.5mcg; hémagglutinine-souche a (h3n2) 7.5mcg; hémagglutinine-souche b (victoria) 7.5mcg; hémagglutinine-souche b (yamagata) 7.5mcg - vaccines

Canadá - francês - Health Canada

sanofi pasteur limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémagglutinine-souche b (victoria); hémagglutinine-souche b (yamagata) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - hémagglutinine-souche a (h1n1) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémagglutinine-souche b (victoria) 15mcg; hémagglutinine-souche b (yamagata) 15mcg - vaccines

Canadá - francês - Health Canada

seqirus uk limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémaglutinine-souche b - suspension - 15mcg; 15mcg; 15mcg - hémagglutinine-souche a (h1n1) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémaglutinine-souche b 15mcg - vaccines

Canadá - francês - Health Canada

sanofi pasteur limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémaglutinine-souche b - suspension - 60mcg; 60mcg; 60mcg - hémagglutinine-souche a (h1n1) 60mcg; hémagglutinine-souche a (h3n2) 60mcg; hémaglutinine-souche b 60mcg - vaccines

União Europeia - francês - EMA (European Medicines Agency)

zoetis belgium sa - le circovirus porcin (vaccin inactivé, recombinant) - immunologicals for suidae, inactivated viral vaccines - les porcs (pour l'engraissement) - pour active la vaccination des porcs à partir de 3 semaines d'âge contre le circovirus porcin de type 2 (pcv2) afin de réduire la charge virale dans le sang et les tissus lymphoïdes et les matières fécales causée par une infection par le pcv2.